Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
993 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00768755 | Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 180 | PfizerINDUSTRY | 11 | Oct 28, 2015 | clinicaltrials |
| NCT01337050 | Asian Phase I Study Of PF-03446962 | completed | Phase 1 | 36 | PfizerINDUSTRY | 2 | Oct 28, 2015 | clinicaltrials |
| NCT01553656 |
| Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer |
| completed |
| Phase 1 |
| 85 |
| ExelixisINDUSTRY |
| 1 |
| Aug 20, 2015 |
| clinicaltrials |
| NCT01435863 | A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) | completed | Phase 1 | 17 | Solasia Pharma K.K.INDUSTRY | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01908387 | Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms | terminated | Phase 1 | 2 | Celgene CorporationINDUSTRY | 1 | Jul 28, 2015 | clinicaltrials |
| NCT02502994 | Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC | unknown | Phase 1 | 12 | Norio NonomuraOTHER | 1 | Jul 20, 2015 | clinicaltrials |
| NCT00624182 | Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer | suspended | Phase 1 | 9 | Akita University HospitalOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01344876 | Phase I Study of OPB-51602 in Patients With Hematologic Malignancies | completed | Phase 1 | 20 | Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01406574 | Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 23 | Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01602289 | A Study of LY2875358 in Japanese Participants With Advanced Cancer | completed | Phase 1 | 17 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00641615 | Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer | completed | Phase 1 | 18 | Kazuhiko YoshimatsuOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00832819 | E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 28 | Eisai Co., Ltd.INDUSTRY | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00923182 | A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia | completed | Phase 1 | 6 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Apr 30, 2015 | clinicaltrials |
| NCT01596088 | A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents | completed | Phase 1 / Phase 2 | 2 | Kissei Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 7, 2015 | clinicaltrials |
| NCT00553696 | Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer | completed | Phase 1 | 27 | PfizerINDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT02100917 | Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults | completed | Phase 1 | 70 | Meiji Seika Pharma Co., Ltd.INDUSTRY | 1 | Feb 10, 2015 | clinicaltrials |
| NCT01324583 | Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer | completed | Phase 1 | 48 | SanofiINDUSTRY | 1 | Jan 7, 2015 | clinicaltrials |
| NCT00375453 | Dose Escalation Study of SH U04722 in Solid Tumors | terminated | Phase 1 | 10 | BayerINDUSTRY | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01340040 | Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects | completed | Phase 1 | 10 | AstraZenecaINDUSTRY | 1 | Dec 11, 2014 | clinicaltrials |
| NCT01392924 | Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors | completed | Phase 1 | 10 | SanofiINDUSTRY | 1 | Dec 3, 2014 | clinicaltrials |
| NCT01329549 | Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC) | terminated | Phase 1 | 2 | Boehringer IngelheimINDUSTRY | 1 | Nov 27, 2014 | clinicaltrials |
| NCT01259505 | Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer | completed | Phase 1 | 10 | Tokyo Medical UniversityOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01610050 | A Phase I Study of LFA102 in Japanese Patients | completed | Phase 1 | 14 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 11, 2014 | clinicaltrials |
| NCT02134262 | Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes | unknown | Phase 1 / Phase 2 | 18 | Jichi Medical UniversityOTHER | 1 | Nov 6, 2014 | clinicaltrials |
| NCT01291615 | Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer | completed | Phase 1 | 6 | Kansai Hepatobiliary Oncology GroupNETWORK | 1 | Oct 23, 2014 | clinicaltrials |
| NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | completed | Phase 1 | 6 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00968916 | Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors | completed | Phase 1 | 15 | SanofiINDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT01905111 | A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer | completed | Phase 1 | 21 | Boehringer IngelheimINDUSTRY | 2 | Sep 4, 2014 | clinicaltrials |
| NCT01165216 | Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer | completed | Phase 1 | 15 | Bristol-Myers SquibbINDUSTRY | 1 | Jul 22, 2014 | clinicaltrials |
| NCT01003158 | Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. | completed | Phase 1 | 17 | AstraZenecaINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01284413 | Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer | completed | Phase 1 / Phase 2 | 68 | Kansai Hepatobiliary Oncology GroupNETWORK | 1 | Jul 1, 2014 | clinicaltrials |
| NCT01722825 | Study of LY2157299 in Japanese Participants With Cancer | completed | Phase 1 | 12 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 1, 2014 | clinicaltrials |
| NCT01005355 | Study of IMC-1121B in Patients With Advanced Solid Tumors | completed | Phase 1 | 15 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT01253525 | Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas | completed | Phase 1 | 6 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT01256567 | A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer | completed | Phase 1 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT01401504 | Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors | completed | Phase 1 | 29 | Astellas Pharma IncINDUSTRY | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01309412 | A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma | terminated | Phase 1 | 9 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | May 19, 2014 | clinicaltrials |
| NCT00494221 | A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX | completed | Phase 1 / Phase 2 | 172 | AstraZenecaINDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01090167 | A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML) | completed | Phase 1 | 14 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT01196013 | A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia | completed | Phase 1 | 7 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT01428141 | A Phase I Study of E7050 in Subjects With Solid Tumors | completed | Phase 1 | 18 | Eisai Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00165594 | A Study of E7070 in Patients With Gastric Cancer | terminated | Phase 1 / Phase 2 | 50 | Eisai Co., Ltd.INDUSTRY | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00985959 | A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT) | completed | Phase 1 | 101 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | Dec 2, 2013 | clinicaltrials |
| NCT00842244 | Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer | completed | Phase 1 | 22 | PfizerINDUSTRY | 2 | Nov 27, 2013 | clinicaltrials |
| NCT00919737 | Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme | completed | Phase 1 / Phase 2 | 24 | NobelpharmaINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00545246 | A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients | completed | Phase 1 | 12 | SanofiINDUSTRY | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01095302 | Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors | completed | Phase 1 | 11 | SanofiINDUSTRY | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00823355 | Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies | completed | Phase 1 | 24 | Mundipharma K.K.INDUSTRY | 1 | Sep 23, 2013 | clinicaltrials |
| NCT00633724 | Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 | 9 | Fukushima Medical UniversityOTHER | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00874588 | Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 | 6 | Fukushima Medical UniversityOTHER | 1 | Aug 15, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials